RESEARCH DATABASE

InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition. With our long history in the industry, we provide more than 7,000 research publications.

Printable list of studies

Download Annual Studies PDF

Use the search box below to find key terms in research papers. For category-specific or recommended results, use the dropdown lists provided.
Research title with ★ indicates InBody recommended paper.

Impact of the 8-week administration of tofogliflozin for glycemic control and body composition in Japanese patients with type 2

Endocrinology
Author
Hirose S et al.
Used Parameters : TBW, ECW, ICW, FFM, BFM, PBF, WHR
Publication Year : 2016
Country : Japan
Journal : Internal Medicine
Objective The adverse effects of selective sodium-glucose co-transporter 2 (SGLT2) inhibitors generally appear within about two or three months after treatment initiation in Japan. Therefore, we investigated the impact of tofogliflozin, a class of SGLT2 inhibitors, on glycemic control and body composition during this period in Japanese patients with type 2 diabetes mellitus. Methods This single-arm open-label study enrolled 20 patients. Patients received tofogliflozin 20 mg once daily for 8 weeks. At week 8, changes from baseline in …
Full text
n-3 PUFA and caloric restriction diet alters lipidomic profiles in obese men with metabolic syndrome: a preliminary open study »
List
Powered by KBoard